October 2021 - We are delighted to share that the second module on treatment-free remission (TFR), is now available on the iCMLf Knowledge Centre.
This new module features five presentations on this important topic to help clinicians conducting TFR attempts and to manage patient appropriately during these attempts.

Learn more in a short video overview from Professor Tim Hughes, who co-chairs this module together with Dr Katia Pagnano from Brazil.

Now find out more about recent scientific findings and practical considerations on TFR.

iCMLf Knowledge Centre – second module on Treatment-Free Remission available to view

The second module outlines current considerations to meet the goal of treatment-free remission for patients with CML:

• Understanding the biological nature of TFR
  Professor Mhairi Copland (University of Glasgow, UK)
• Identifying the best candidates for TFR
  Dr Naranie Shanmuganathan (Royal Hospital/SA Pathology Adelaide, Australia)
• The ideal – when TFR can be recommended
  Professor Tim Hughes (SAHMRI/University of Adelaide, Australia)
  Professor Ehab Atallah (Medical College of Wisconsin, USA)
• The practical – how to implement TFR in resource constrained centres
  Dr Katia Pagnano (University of Campinas Sao Paulo, Brazil)
  Professor Hemant Malhotra (Mahatma Gandhi Medical College Hospital
  Jaipur, India)
• How to communicate with patients about TFR
  Professor Gianantonio Rosti (IRCCS/SIRHHC Scientific Institute for Research, Hospitalization and Health Care Meldola (FC), Italy)

Access all presentations of module 2 here

If you have any questions or comments on the presentations for the speakers or the community, you can leave a comment on the discussion section.

A big THANK YOU goes to all experts of this second module for their valuable contribution and to Novartis Oncology for the support that made this program possible.

Additional educational modules on lessons from the laboratory for both clinicians and scientists and management practicalities will be launched fortnightly over the next couple of weeks.

We hope that this module will guide you safely through TFR considerations for your patients.